Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Melvin L.K. Chua"'
Autor:
Li YQ; You Quan Li, Sze Huey Tan, Grace Kusumawidjaja, Enya H.W. Ong, Terence W.K. Tan, Kam Weng Fong, Kiattisa Sommat, Yoke Lim Soong, Joseph T.S. Wee, and Melvin L.K. Chua, National Cancer Centre Singapore; Terence W.K. Tan, Kam Weng Fong, Yoke Lim Soong, Joseph T.S. Wee, and Melvin L.K. Chua, Duke-National University of Singapore Medical School, Singapore; Yun Ming Tian, Huizhou Municipal Central Hospital, Huizhou; and Ming Zhu Liu, Chong Zhao, and Fei Han, Collaborative Innovation Center for Cancer Medicine, Guangzhou; Sun Yat Sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong, People's Republic of China., Tian YM; You Quan Li, Sze Huey Tan, Grace Kusumawidjaja, Enya H.W. Ong, Terence W.K. Tan, Kam Weng Fong, Kiattisa Sommat, Yoke Lim Soong, Joseph T.S. Wee, and Melvin L.K. Chua, National Cancer Centre Singapore; Terence W.K. Tan, Kam Weng Fong, Yoke Lim Soong, Joseph T.S. Wee, and Melvin L.K. Chua, Duke-National University of Singapore Medical School, Singapore; Yun Ming Tian, Huizhou Municipal Central Hospital, Huizhou; and Ming Zhu Liu, Chong Zhao, and Fei Han, Collaborative Innovation Center for Cancer Medicine, Guangzhou; Sun Yat Sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong, People's Republic of China., Tan SH; You Quan Li, Sze Huey Tan, Grace Kusumawidjaja, Enya H.W. Ong, Terence W.K. Tan, Kam Weng Fong, Kiattisa Sommat, Yoke Lim Soong, Joseph T.S. Wee, and Melvin L.K. Chua, National Cancer Centre Singapore; Terence W.K. Tan, Kam Weng Fong, Yoke Lim Soong, Joseph T.S. Wee, and Melvin L.K. Chua, Duke-National University of Singapore Medical School, Singapore; Yun Ming Tian, Huizhou Municipal Central Hospital, Huizhou; and Ming Zhu Liu, Chong Zhao, and Fei Han, Collaborative Innovation Center for Cancer Medicine, Guangzhou; Sun Yat Sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong, People's Republic of China., Liu MZ; You Quan Li, Sze Huey Tan, Grace Kusumawidjaja, Enya H.W. Ong, Terence W.K. Tan, Kam Weng Fong, Kiattisa Sommat, Yoke Lim Soong, Joseph T.S. Wee, and Melvin L.K. Chua, National Cancer Centre Singapore; Terence W.K. Tan, Kam Weng Fong, Yoke Lim Soong, Joseph T.S. Wee, and Melvin L.K. Chua, Duke-National University of Singapore Medical School, Singapore; Yun Ming Tian, Huizhou Municipal Central Hospital, Huizhou; and Ming Zhu Liu, Chong Zhao, and Fei Han, Collaborative Innovation Center for Cancer Medicine, Guangzhou; Sun Yat Sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong, People's Republic of China., Kusumawidjaja G; You Quan Li, Sze Huey Tan, Grace Kusumawidjaja, Enya H.W. Ong, Terence W.K. Tan, Kam Weng Fong, Kiattisa Sommat, Yoke Lim Soong, Joseph T.S. Wee, and Melvin L.K. Chua, National Cancer Centre Singapore; Terence W.K. Tan, Kam Weng Fong, Yoke Lim Soong, Joseph T.S. Wee, and Melvin L.K. Chua, Duke-National University of Singapore Medical School, Singapore; Yun Ming Tian, Huizhou Municipal Central Hospital, Huizhou; and Ming Zhu Liu, Chong Zhao, and Fei Han, Collaborative Innovation Center for Cancer Medicine, Guangzhou; Sun Yat Sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong, People's Republic of China., Ong EHW; You Quan Li, Sze Huey Tan, Grace Kusumawidjaja, Enya H.W. Ong, Terence W.K. Tan, Kam Weng Fong, Kiattisa Sommat, Yoke Lim Soong, Joseph T.S. Wee, and Melvin L.K. Chua, National Cancer Centre Singapore; Terence W.K. Tan, Kam Weng Fong, Yoke Lim Soong, Joseph T.S. Wee, and Melvin L.K. Chua, Duke-National University of Singapore Medical School, Singapore; Yun Ming Tian, Huizhou Municipal Central Hospital, Huizhou; and Ming Zhu Liu, Chong Zhao, and Fei Han, Collaborative Innovation Center for Cancer Medicine, Guangzhou; Sun Yat Sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong, People's Republic of China., Zhao C; You Quan Li, Sze Huey Tan, Grace Kusumawidjaja, Enya H.W. Ong, Terence W.K. Tan, Kam Weng Fong, Kiattisa Sommat, Yoke Lim Soong, Joseph T.S. Wee, and Melvin L.K. Chua, National Cancer Centre Singapore; Terence W.K. Tan, Kam Weng Fong, Yoke Lim Soong, Joseph T.S. Wee, and Melvin L.K. Chua, Duke-National University of Singapore Medical School, Singapore; Yun Ming Tian, Huizhou Municipal Central Hospital, Huizhou; and Ming Zhu Liu, Chong Zhao, and Fei Han, Collaborative Innovation Center for Cancer Medicine, Guangzhou; Sun Yat Sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong, People's Republic of China., Tan TWK; You Quan Li, Sze Huey Tan, Grace Kusumawidjaja, Enya H.W. Ong, Terence W.K. Tan, Kam Weng Fong, Kiattisa Sommat, Yoke Lim Soong, Joseph T.S. Wee, and Melvin L.K. Chua, National Cancer Centre Singapore; Terence W.K. Tan, Kam Weng Fong, Yoke Lim Soong, Joseph T.S. Wee, and Melvin L.K. Chua, Duke-National University of Singapore Medical School, Singapore; Yun Ming Tian, Huizhou Municipal Central Hospital, Huizhou; and Ming Zhu Liu, Chong Zhao, and Fei Han, Collaborative Innovation Center for Cancer Medicine, Guangzhou; Sun Yat Sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong, People's Republic of China., Fong KW; You Quan Li, Sze Huey Tan, Grace Kusumawidjaja, Enya H.W. Ong, Terence W.K. Tan, Kam Weng Fong, Kiattisa Sommat, Yoke Lim Soong, Joseph T.S. Wee, and Melvin L.K. Chua, National Cancer Centre Singapore; Terence W.K. Tan, Kam Weng Fong, Yoke Lim Soong, Joseph T.S. Wee, and Melvin L.K. Chua, Duke-National University of Singapore Medical School, Singapore; Yun Ming Tian, Huizhou Municipal Central Hospital, Huizhou; and Ming Zhu Liu, Chong Zhao, and Fei Han, Collaborative Innovation Center for Cancer Medicine, Guangzhou; Sun Yat Sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong, People's Republic of China., Sommat K; You Quan Li, Sze Huey Tan, Grace Kusumawidjaja, Enya H.W. Ong, Terence W.K. Tan, Kam Weng Fong, Kiattisa Sommat, Yoke Lim Soong, Joseph T.S. Wee, and Melvin L.K. Chua, National Cancer Centre Singapore; Terence W.K. Tan, Kam Weng Fong, Yoke Lim Soong, Joseph T.S. Wee, and Melvin L.K. Chua, Duke-National University of Singapore Medical School, Singapore; Yun Ming Tian, Huizhou Municipal Central Hospital, Huizhou; and Ming Zhu Liu, Chong Zhao, and Fei Han, Collaborative Innovation Center for Cancer Medicine, Guangzhou; Sun Yat Sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong, People's Republic of China., Soong YL; You Quan Li, Sze Huey Tan, Grace Kusumawidjaja, Enya H.W. Ong, Terence W.K. Tan, Kam Weng Fong, Kiattisa Sommat, Yoke Lim Soong, Joseph T.S. Wee, and Melvin L.K. Chua, National Cancer Centre Singapore; Terence W.K. Tan, Kam Weng Fong, Yoke Lim Soong, Joseph T.S. Wee, and Melvin L.K. Chua, Duke-National University of Singapore Medical School, Singapore; Yun Ming Tian, Huizhou Municipal Central Hospital, Huizhou; and Ming Zhu Liu, Chong Zhao, and Fei Han, Collaborative Innovation Center for Cancer Medicine, Guangzhou; Sun Yat Sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong, People's Republic of China., Wee JTS; You Quan Li, Sze Huey Tan, Grace Kusumawidjaja, Enya H.W. Ong, Terence W.K. Tan, Kam Weng Fong, Kiattisa Sommat, Yoke Lim Soong, Joseph T.S. Wee, and Melvin L.K. Chua, National Cancer Centre Singapore; Terence W.K. Tan, Kam Weng Fong, Yoke Lim Soong, Joseph T.S. Wee, and Melvin L.K. Chua, Duke-National University of Singapore Medical School, Singapore; Yun Ming Tian, Huizhou Municipal Central Hospital, Huizhou; and Ming Zhu Liu, Chong Zhao, and Fei Han, Collaborative Innovation Center for Cancer Medicine, Guangzhou; Sun Yat Sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong, People's Republic of China., Han F; You Quan Li, Sze Huey Tan, Grace Kusumawidjaja, Enya H.W. Ong, Terence W.K. Tan, Kam Weng Fong, Kiattisa Sommat, Yoke Lim Soong, Joseph T.S. Wee, and Melvin L.K. Chua, National Cancer Centre Singapore; Terence W.K. Tan, Kam Weng Fong, Yoke Lim Soong, Joseph T.S. Wee, and Melvin L.K. Chua, Duke-National University of Singapore Medical School, Singapore; Yun Ming Tian, Huizhou Municipal Central Hospital, Huizhou; and Ming Zhu Liu, Chong Zhao, and Fei Han, Collaborative Innovation Center for Cancer Medicine, Guangzhou; Sun Yat Sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong, People's Republic of China., Chua MLK; You Quan Li, Sze Huey Tan, Grace Kusumawidjaja, Enya H.W. Ong, Terence W.K. Tan, Kam Weng Fong, Kiattisa Sommat, Yoke Lim Soong, Joseph T.S. Wee, and Melvin L.K. Chua, National Cancer Centre Singapore; Terence W.K. Tan, Kam Weng Fong, Yoke Lim Soong, Joseph T.S. Wee, and Melvin L.K. Chua, Duke-National University of Singapore Medical School, Singapore; Yun Ming Tian, Huizhou Municipal Central Hospital, Huizhou; and Ming Zhu Liu, Chong Zhao, and Fei Han, Collaborative Innovation Center for Cancer Medicine, Guangzhou; Sun Yat Sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong, People's Republic of China.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2018 Mar 20; Vol. 36 (9), pp. 891-899. Date of Electronic Publication: 2018 Feb 07.
Autor:
Fei Han, Kah Hie Wong, Wei-Xiong Xia, Jingjing Miao, Xiang Guo, Yan-Qing Cao, Yan-Qun Xiang, Joseph Wee, Huageng Huang, Weiwei Xiao, Melvin L.K. Chua, Chong Zhao, Boyu Chen, Shaomin Huang, Xiaowu Deng, Muping Di, Luo Huang, Xing Lv, Lin Wang, Manyi Zhu, Sze Huey Tan
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 107:672-682
Purpose Current guideline recommends a uniform method of delineation of subclinical disease within the primary clinical target volume (CTVp) for all stages of nasopharyngeal carcinoma (NPC). We performed a prospective observational study to investiga
Autor:
M. McGrath, Jazmina Gonzalez‐Cruz, Sandro V. Porceddu, Ben Wallwork, Chris T. Perry, Catherine M. E. Barnett, Lewis Overton, Melvin L.K. Chua, Benedict Panizza, Liam Masterson, Matt Lechner, Terry Jones, James Howard, Christopher Jackson, Rahul Ladwa, Christian H. Ottensmeier, Rajiv Khanna, Howard Liu, Fiona Simpson
Publikováno v:
International Journal of Cancer. 146:2305-2314
Now is an exciting era of development in immunotherapy checkpoint inhibitors and their effect on the treatment of NPC. While the general prognosis of R/M disease is poor, immunotherapy offers some promise in a malignancy associated with EBV and chara
Autor:
Kuan Rui Lloyd Tan, Zhen-Yu Qi, Haitao Wang, Li Lin, Rui-Qi Liu, Jia-Wei Lv, Yue Chen, Ying Sun, Xiao-Dan Huang, Melvin L.K. Chua, Jun Ma, Lu-Lu Zhang, Yu Pei Chen, Si-Si Xu, Guan-Qun Zhou, Fo-Ping Chen
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-10 (2019)
Nature Communications
Nature Communications
Liquid biopsies have the utility for detecting minimal residual disease in several cancer types. Here, we investigate if liquid biopsy tracking on-treatment informs on tumour phenotypes by longitudinally quantifying circulating Epstein-barr virus (EB
Publikováno v:
The Lancet. Oncology. 22(6)
Publikováno v:
Cancer Communications, Vol 39, Iss 1, Pp 1-3 (2019)
Cancer Communications
Cancer Communications
The goal of this study was to explore the value of adding neoadjuvant chemotherapy (NACT) or adjuvant chemotherapy (ACT) to concurrent chemoradiotherapy (CCRT) in patients with nasopharyngeal carcinoma (NPC) with different risks of treatment failure.
Autor:
Wei Lin Chen, Joseph Wee, Yueming Jin, Chuan Miao Xie, Guan Qun Zhou, Hao Chen, Jun Ma, Ying Sun, Ling Long Tang, Feng Liu, Li Lin, Ning Jiang, Melvin L.K. Chua, Pheng-Ann Heng, Shao Min Huang, Bao An Su, Chang Juan Tao, Yi Qiang Tang, Jun Yun Li, Qi Dou
Publikováno v:
Radiology. 291:677-686
Background Nasopharyngeal carcinoma (NPC) may be cured with radiation therapy. Tumor proximity to critical structures demands accuracy in tumor delineation to avoid toxicities from radiation therapy; however, tumor target contouring for head and neck
Autor:
Jingjing Miao, Chong Zhao, Xi Chen, Jun Chen, Melvin L.K. Chua, M. Shi, Fei Han, X. Hu, G.-P. Shen, X. Shao, Jia Li, N. Zhang, Hai-Qiang Mai, Conghua Xie, Guoqing Hu, Lin Wang, Shiwei Wu
Publikováno v:
Annals of Oncology. 30:637-643
We conducted a single-arm phase II trial to evaluate the efficacy and adverse effects (AEs) of an anti-epidermal growth factor receptor monoclonal antibody, nimotuzumab, combined with cisplatin and 5-fluorouracil (PF) as first-line treatment in recur
Autor:
Yoke Lim Soong, Kevin L.M. Chua, Terence Wee Kiat Tan, Eugenia Li Ling Yeo, Enya Hui Wen Ong, Paula Y.P. Lam, Joseph Wee, Kam Weng Fong, Melvin L.K. Chua, Sze Huey Tan, Waseem Ahamed Shihabudeen, Khee Chee Soo, Than Than Shwe
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-11 (2018)
BMC Cancer
BMC Cancer
Background Inter-patient heterogeneity in radiation-induced DNA damage responses is proposed to reflect intrinsic variations in tumour and normal tissue radiation sensitivity, but the prediction of phenotype by a molecular biomarker is influenced by
Autor:
Shao Hui Huang, Quynh-Thu Le, Jun Ma, Sue S. Yom, Nofisat Ismaila, Yu Pei Chen, Anne W.M. Lee, Jin-Ching Lin, Melvin L.K. Chua, Jatin P. Shah, Brigette B.Y. Ma, Robert I. Haddad, Thomas J Morgan, Alexander C Whitley, Jun-Lin Yi, Nancy Y. Lee, Joseph Wee, Anthony T.C. Chan, Chaosu Hu, A. Dimitrios Colevas, Ying Sun, Jinyi Lang
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 39(7)
PURPOSE The aim of this joint guideline is to provide evidence-based recommendations to practicing physicians and other healthcare providers on definitive-intent chemoradiotherapy for patients with stage II-IVA nasopharyngeal carcinoma (NPC). METHODS